ATL revenues up, net loss drops

Article

Ultrasound vendor Advanced TechnologyLaboratories reported higher revenues for its third quarter (end-September),but ended the quarter with a net loss due to higher operatingexpenses associated with product introductions such as the company'snew HDI 3000

Ultrasound vendor Advanced TechnologyLaboratories reported higher revenues for its third quarter (end-September),but ended the quarter with a net loss due to higher operatingexpenses associated with product introductions such as the company'snew HDI 3000 scanner.

ATL, of Bothell, WA, recorded third-quarter revenues of $87.3million, up 11% over the $78.6 million in the same period lastyear. The company had a net loss of $4.8 million in the quarterversus a net loss of $8.5 million in the third quarter of 1993.The 1993 results included a $4.3 million restructuring charge(SCAN 9/8/93).

The company's investment in new product development was reflectedin a 19% increase in R&D expenses, to $15.1 million. Salesand administrative costs rose 8% to $28.5 million due to the initialcosts of launching HDI 3000, as well as international expansionand the introduction of Interspec's Apogee products, which ATLacquired earlier this year (SCAN 2/16/94). Those products arebeginning to contribute to growth in ATL's international business.

For the first nine months of 1994, ATL had revenues of $261.5million and a net loss of $14.4 million, which includes one-timeexpenses of $5.4 million for the Interspec acquisition. In thesame period last year, ATL's revenues were $262 million and itsnet loss was $7.7 million.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.